Literature DB >> 24113214

Nanoparticles containing insoluble drug for cancer therapy.

Shutao Guo1, Leaf Huang2.   

Abstract

Nanoparticle drug formulations have been extensively researched and developed in the field of drug delivery as a means to efficiently deliver insoluble drugs to tumor cells. By mechanisms of the enhanced permeability and retention effect, nanoparticle drug formulations are capable of greatly enhancing the safety, pharmacokinetic profiles and bioavailability of the administered treatment. Here, the progress of various nanoparticle formulations in both research and clinical applications is detailed with a focus on the development of drug/gene delivery systems. Specifically, the unique advantages and disadvantages of polymeric nanoparticles, liposomes, solid lipid nanoparticles, nanocrystals and lipid-coated nanoparticles for targeted drug delivery will be investigated in detail.
© 2013.

Entities:  

Keywords:  Calcium phosphate; Drug delivery; Gold nanoparticle; Lipid; Liposome; Nanocrystals; Nanoparticle; Polymer; siRNA

Mesh:

Substances:

Year:  2013        PMID: 24113214      PMCID: PMC3980181          DOI: 10.1016/j.biotechadv.2013.10.002

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  139 in total

1.  Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine.

Authors:  Jubo Liu; Yuehua Xiao; Christine Allen
Journal:  J Pharm Sci       Date:  2004-01       Impact factor: 3.534

Review 2.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

3.  A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy.

Authors:  A N Vis; A van der Gaast; B W G van Rhijn; T K Catsburg; C Schmidt; G H J Mickisch
Journal:  Cancer Chemother Pharmacol       Date:  2002-01-30       Impact factor: 3.333

Review 4.  Approaches for the preparation of non-linear amphiphilic polymers and their applications to drug delivery.

Authors:  Yi Wang; Scott M Grayson
Journal:  Adv Drug Deliv Rev       Date:  2012-03-21       Impact factor: 15.470

5.  Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy.

Authors:  Yuan Zhang; William Y Kim; Leaf Huang
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

6.  Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells.

Authors:  Chae Kyu Kim; Partha Ghosh; Chiara Pagliuca; Zheng-Jiang Zhu; Stefano Menichetti; Vincent M Rotello
Journal:  J Am Chem Soc       Date:  2009-02-04       Impact factor: 15.419

7.  Clinical and pharmacologic study of the novel prodrug delimotecan (MEN 4901/T-0128) in patients with solid tumors.

Authors:  Stephan A Veltkamp; Els O Witteveen; Angela Capriati; Attilio Crea; Fabio Animati; Marja Voogel-Fuchs; Ingeborg J G M van den Heuvel; Jos H Beijnen; Emile E Voest; Jan H M Schellens
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

8.  Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B.

Authors:  André Warnecke; Iduna Fichtner; Gretel Sass; Felix Kratz
Journal:  Arch Pharm (Weinheim)       Date:  2007-08       Impact factor: 3.751

9.  A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer.

Authors:  Michael V Seiden; Franco Muggia; Allan Astrow; Ursula Matulonis; Susanna Campos; Maria Roche; Julia Sivret; Jason Rusk; Emma Barrett
Journal:  Gynecol Oncol       Date:  2004-04       Impact factor: 5.482

10.  Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

Authors:  Michael J Lee; Albert S Ye; Alexandra K Gardino; Anne Margriet Heijink; Peter K Sorger; Gavin MacBeath; Michael B Yaffe
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

View more
  31 in total

1.  Drug Delivery and Nanoformulations for the Cardiovascular System.

Authors:  W J Geldenhuys; M T Khayat; J Yun; M A Nayeem
Journal:  Res Rev Drug Deliv       Date:  2017-03-07

2.  TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments.

Authors:  Dylan K McDaniel; Ami Jo; Veronica M Ringel-Scaia; Sheryl Coutermarsh-Ott; Daniel E Rothschild; Michael D Powell; Rui Zhang; Timothy E Long; Kenneth J Oestreich; Judy S Riffle; Richey M Davis; Irving C Allen
Journal:  Nanomedicine       Date:  2016-12-29       Impact factor: 5.307

3.  Inhibiting PI3 kinase-γ in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors.

Authors:  Xueqiong Zhang; Limei Shen; Qi Liu; Lin Hou; Leaf Huang
Journal:  J Control Release       Date:  2019-07-29       Impact factor: 9.776

4.  Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model.

Authors:  Elham Ajorlou; Ahmad Yari Khosroushahi; Hamid Yeganeh
Journal:  Pharm Res       Date:  2016-02-23       Impact factor: 4.200

Review 5.  miRNA nanotherapeutics for cancer.

Authors:  Aditya Ganju; Sheema Khan; Bilal B Hafeez; Stephen W Behrman; Murali M Yallapu; Subhash C Chauhan; Meena Jaggi
Journal:  Drug Discov Today       Date:  2016-11-01       Impact factor: 7.851

Review 6.  Applications and perspectives of nanomaterials in novel vaccine development.

Authors:  Yingbin Shen; Tianyao Hao; Shiyi Ou; Churan Hu; Long Chen
Journal:  Medchemcomm       Date:  2017-10-17       Impact factor: 3.597

Review 7.  Nanoformulations for combination or cascade anticancer therapy.

Authors:  Lei Miao; Shutao Guo; C Michael Lin; Qi Liu; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2017-06-15       Impact factor: 15.470

8.  Micelle Delivery of Parthenolide to Acute Myeloid Leukemia Cells.

Authors:  Michael P Baranello; Louisa Bauer; Craig T Jordan; Danielle S W Benoit
Journal:  Cell Mol Bioeng       Date:  2015-04-25       Impact factor: 2.321

Review 9.  Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.

Authors:  Simeon K Adesina; Emmanuel O Akala
Journal:  Mol Pharm       Date:  2015-11-09       Impact factor: 4.939

Review 10.  Recent advances of cocktail chemotherapy by combination drug delivery systems.

Authors:  Quanyin Hu; Wujin Sun; Chao Wang; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2015-11-06       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.